R. Ken Coit

U of A launches rapamycin clinical trial with philanthropic support of alumnus Ken Coit

Researchers at the R. Ken Coit College of Pharmacy will begin a double-blind, randomized Phase 3 clinical trial this year to evaluate whether a drug used to prevent organ transplant rejection can also